2 results
Approved WMORecruiting
Primary: To assess the proportion of patients with intervention failure at 12 months after dose reduction, defined as patients who have restarted their initial dose due to (expected) loss of major molecular response.
Approved WMORecruiting
The primary objective of this exploratory proof of concept clinical investigation is to confirm bulb catheter*s performance in adults already using Navina Smart.The secondary objectives and endpoints are to evaluate bowel emptying performance of…